"didn't know if GERN was slated to get any revenue from it"
IMO the very last business, where GERN would decide to focus would be in the "pet cloning" business. IMO they would loose all credibility with the medical and scientific community if they made this decision.
GERN already owns the rights to "Dolly" the sheep that was cloned, but the emphasis of GERN IMO is to do with treatments that would benefit humans.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.